Science News about Treatments (All Items)

Find Science News by Topic

Or Find Science News by Year

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002

Science/AAAS Webinar on Translational Neuroscience Research Featuring NIMH’s Carlos A. Zarate, M.D.
Science Update • February 14, 2013
Carlos Zarate, MD

Want to know how the latest findings in neuroscience research go from bench to bedside? NIMH and Science/AAAS partnered to produce an informative webinar on translating neurobiological research into treatments.

HHS Secretary Kathleen Sebelius on the State of Mental Health Care in the United States
Science Update • February 05, 2013
HHS Secretary Kathleen Sebelius

HHS Secretary Kathleen Sebelius discusses state of U.S. mental health care, commemorates JFK’s speech on the topic 50 years ago.

50 years ago, President John F. Kennedy Sent a Special Message to Congress About the State of Mental Health
Science Update • January 29, 2013
Celebrating JFK’s Mental Health Speech

Fifty years ago, President John F. Kennedy addressed Congress about the state of mental health—and changed the way Americans view mental health care.

Experimental Agent Briefly Eases Depression Rapidly in Test
Press Release • December 11, 2012
brain matrix

Ketamine-like agent lifts depression briefly in treatment-resistant patients, with few side effects.

Couple’s Therapy Appears to Decrease PTSD Symptoms, Improve RelationshipExternal Link: Please review our disclaimer.
Science Update • August 14, 2012
adult couple sitting on a bench

Among couples in which one partner was diagnosed as having posttraumatic stress disorder (PTSD), participation in disorder-specific couple therapy resulted in decreased PTSD symptom severity and increased patient relationship satisfaction, compared with couples who were placed on a wait list for the therapy, according to a study in the August 15 issue of JAMA, a theme issue on violence and human rights.

Brain Signal ID’s Responders to Fast-Acting Antidepressant
Press Release • August 03, 2012
MEG scan

Biomarkers identified in research on a fast-acting antidepressant can signal who will respond to the medication and are providing clues to how it works to lift depression.

NIH-funded Study Defines Treatment Window for HIV-positive Children Infected at Birth
Press Release • March 07, 2012
mother holds baby boy

HIV-positive children older than 1 year who were treated after showing moderate HIV-related symptoms did not experience greater cognitive or behavior problems compared to peers treated when signs of their infection were still mild, according to a study funded by the National Institutes of Health.

Training Peers Improves Social Outcomes for Some Kids with ASD
Press Release • November 28, 2011
young children play outside

Children with autism spectrum disorder (ASD) who attend regular education classes may be more likely to improve their social skills if their typically developing peers are taught how to interact with them than if only the children with ASD are taught such skills. According to a study funded by the National Institutes of Health, a shift away from more commonly used interventions that focus on training children with ASD directly may provide greater social benefits for children with ASD.

Perinatal Antidepressant Stunts Brain Development in Rats
Press Release • October 24, 2011
abnormal axon

Rats exposed to an antidepressant just before and after birth showed substantial brain abnormalities and behaviors, in a study funded by the National Institutes of Health.

For Minor Depression, Study Shows No Benefit Over Placebo from St. John’s Wort, Citalopram
Science Update • July 22, 2011
yellow flower

An extract of the herb St. John's Wort and a standard antidepressant medication both failed to outdo a placebo in relieving symptoms of minor depression in a clinical trial comparing the three. The results of this study, consistent with earlier research, do not in support the use of medications for mild depression.

Drug Boosts Growth Factor to Jump-start Rapid Antidepressant Response
Press Release • June 22, 2011
ketamine mechanism of action

A study in mice has pinpointed a pivotal new player in triggering the rapid antidepressant response produced by ketamine. By deactivating a little-known enzyme, the drug takes the brakes off rapid synthesis of a key growth factor thought to lift depression, say researchers supported by the National Institutes of Health.

Toddlers with Autism Show Improved Social Skills Following Targeted Intervention, Finds NIH-Supported Study
Press Release • December 08, 2010
boy painting his shirt

Targeting the core social deficits of autism spectrum disorders (ASD) in early intervention programs yielded sustained improvements in social and communication skills even in very young children who have ASD, according to a study funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study was published online July 28, 2010, in the Journal of Child Psychology and Psychiatry.

Experimental Medication Lifts Depression Symptoms in Bipolar Disorder Within an Hour
Science Update • August 06, 2010
lighted brain with blue glow

People with treatment-resistant bipolar disorder experienced relief from symptoms of depression in as little as 40 minutes after an intravenous dose of the anesthetic medication ketamine in a preliminary study; while the patient group was small, this work adds to evidence that compounds in the class to which ketamine belongs have potential as rapid and effective medications for depression, including bipolar depression.

Just Over Half of Americans Diagnosed with Major Depression Receive Care
Science Update • January 04, 2010
man and woman on ground

Overall, only about half of Americans diagnosed with major depression in a given year receive treatment for it, and even fewer—about one fifth—receive treatment consistent with current practice guidelines, according to data from nationally representative surveys supported by NIMH. Among the ethnic/racial groups surveyed, African Americans and Mexican Americans had the lowest rates of use of depression care; all groups reported higher use of past-year psychotherapy vs. medication for depression.

Autism Intervention for Toddlers Improves Developmental Outcomes
Science Update • December 08, 2009
Adult swinging child, playing outside

Children with autism who receive a high intensity developmental behavioral intervention starting by age 18–30 months show major improvements in IQ, language, adaptive behavior, and severity of their diagnosis, according to an NIMH-funded study.

NIH Encourages Depressed Moms to Seek Treatment for Themselves
Science Update • November 13, 2009
woman holding child while sitting on a chair

Numerous studies have suggested that depression runs in families. Children of depressed parents are 2–3 times as likely to develop depression as compared to children who do not have a family history of the disorder. Other studies have shown that remission of depression in mothers is associated with improvements in psychiatric symptoms in their children. Despite all signs encouraging mothers to prioritize their own mental health, many suffer from untreated depression while managing treatment for their children’s emotional or behavioral problems.

Recovery Act Grant Aims to Teach Kids with Autism How to Better Express Themselves
Science Update • November 12, 2009
woman and boy with laptop

Most children with autism spectrum disorders (ASD) seem to have trouble engaging in everyday social interactions. They may seem to have no reaction to other people or may respond atypically when others show anger or affection. Their own facial expressions, tone of voice, and body language may not match what they are saying, making it difficult for others to respond appropriately. Such barriers to communication can isolate children with ASD from their peers.

Major NIMH Research Project to Test Approaches to Altering the Course of Schizophrenia
Press Release • July 21, 2009

The National Institute of Mental Health (NIMH) is launching a large-scale research project to explore whether using early and aggressive treatment, individually targeted and integrating a variety of different therapeutic approaches, will reduce the symptoms and prevent the gradual deterioration of functioning that is characteristic of chronic schizophrenia.

New NIMH Video Describes Depression, Importance of Treatment
Science Update • June 02, 2009
man and woman holding hands

A new 4-minute video from the National Institute of Mental Health provides an overview for the general public on the symptoms, impact, and treatment of depression. The video is available for viewing by individuals or can be used by community groups or in health care offices to inform viewers about depression and its consequences, and the critical importance of seeking treatment.

Citalopram No Better Than Placebo Treatment for Children with Autism Spectrum Disorders
Press Release • June 01, 2009
boy playing with a puzzle

Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.

Brain Awareness Week Teaches Kids How Their Brains Work
Press Release • March 17, 2009

The 10th annual Brain Awareness Week (BAW), a science and health education fair held in various locations across the United States, teaches fifth through eighth grade students about the brain. In Washington, D.C., it will take place March 16-20, 2009, at the National Museum of Health and Medicine at Walter Reed Army Medical Center. Several institutes from the National Institutes of Health will provide interactive exhibits and lectures focusing on brain health and neuroscience on March 18th and 19th.

Possible HIV Prevention Therapy Shows Promise, But At a Significant Cost
Science Update • February 11, 2009

A therapy that shows promise in preventing HIV infection could significantly reduce the risk of HIV infection among high-risk groups, but the cost may be substantial unless drug costs can be reduced, according to a study published online ahead of print February 4, 2009, in Clinical Infectious Diseases.

Pilot Study Will Test New Treatment to Reduce Self-Harm in Borderline Personality Disorder
Science Update • October 09, 2008

NIMH recently funded Kim Gratz, Ph.D., University of Mississippi Medical Center, and colleagues to continue to test a new group therapy to help women with borderline personality disorder reduce self-harm behaviors and to improve functioning.

New NIMH Research to Test Innovative Treatments for Children with ADHD
Science Update • June 05, 2008

Two new grants funded by NIMH will focus on novel and innovative approaches to treating children who have attention deficit hyperactivity disorder (ADHD).

NIMH Funds Research to Find Best Treatments for Children with Autism and ADHD Symptoms
Science Update • June 02, 2008

A new NIMH-funded study will help guide the treatment of attention deficit hyperactivity disorder (ADHD) symptoms in children with autism spectrum disorders (ASD).

Preventive Treatment May Help Head Off Depression Following a Stroke
Science Update • May 28, 2008

For the first time, researchers show that preventive treatment with an antidepressant medication or talk therapy can significantly reduce the risk or delay the start of depression following an acute stroke, according to a study funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. These findings differ from past studies attempting to prevent poststroke depression. The study appears in the May 28, 2008, issue of the Journal of the American Medical Association.

Journal Highlights Effectiveness of Research Based Psychotherapies for Youth
Science Update • April 15, 2008

Reviews of the current research on psychosocial and behavioral therapies, or psychotherapies, for children and adolescents found a number of "well established" and "probably efficacious" treatments for many mental disorders. For example, six were "probably efficacious" for anxiety disorders, and two were "well established" for attention deficit hyperactivity disorder (ADHD), according to scientists funded by NIMH and the National Institute on Drug Abuse, divisions of the National Institutes of Health.

New Research to Help People with Mental Disorders Quit Smoking
Science Update • April 04, 2008

A new grant funded by NIMH will develop an intervention designed to help people with serious mental illness (SMI) quit smoking. The addiction is very common among people with SMI, and contributes significantly to deteriorating health and higher costs for care. But it is difficult to treat among people with SMI because they require a tailored approach that is incorporated into their existing mental health treatment.

Group Therapy Program Offers Meaningful Gains for People with Borderline Personality Disorder
Science Update • February 26, 2008

A 20-week group therapy program focusing on cognitive behavioral and skills training, when used in conjunction with usual care, helped reduce symptoms of borderline personality disorder and improve overall functioning, reported NIMH-funded researchers.

Research-based Principles May Help Improve Mental Health Recovery Following Mass Trauma
Science Update • January 14, 2008

Experts on trauma-related research and medical practices from around the world recently identified five principles to guide mental health care efforts immediately or shortly after a mass trauma, such as a natural disaster or terrorist attack. In a related commentary, NIMH scientist Farris Tuma, Sc.D., MHS, discusses how these principles may help determine effective mental health care for large numbers of people following an emergency, and how best to deliver it. The article and commentary were published in the Winter 2007 issue of Psychiatry: Interpersonal and Biological Processes.

Memory-sustaining Enzyme May Help Treat PTSD, Cognitive Decline
Science Update • November 02, 2007

Chemically blocking an enzyme in a specific area in the brain’s cortex, or outer mantle, erased a long-term memory of an aversive event that rats had learned, a study funded in part by NIMH has found.

Internet-based PTSD Therapy May Help Overcome Barriers to Care
Science Update • November 01, 2007

NIMH-funded researchers recently completed a pilot study showing that an Internet-based, self-managed cognitive behavioral therapy (CBT) can help reduce symptoms of post-traumatic stress disorder (PTSD) and depression, with effects that last after treatment has ended.

Family Involvement and Focused Intervention May be Key to Helping Teens with Bulimia
Science Update • September 17, 2007

Family-based treatment for adolescent bulimia nervosa (FBT-BN) is more effective than an individual-based therapy called supportive psychotherapy (SPT) in helping teens overcome bulimia according to an NIMH-funded study.

New Research to Help Youth with Mental Disorders Transition to Adulthood
Science Update • September 05, 2007

As young people with mental health disorders transition from adolescence to adulthood, they frequently face new and difficult challenges such as the loss of state-issued benefits like Medicaid and foster care, or loss of family-based insurance coverage.

Studies Refine Understanding of Treatments for Bipolar Disorder
Science Update • September 01, 2007

Two new studies provide additional details on best practices for treating people with bipolar disorder, a sometimes debilitating illness marked by severe mood swings between depression and mania.

New Technique Pinpoints Crossroads of Depression in Rat Brain
Science Update • August 02, 2007

NIMH-funded scientists have developed a new high-speed technique for imaging brain activity and used it to pinpoint a circuit signal in rats that may be at the crossroads of depression — a possible "final common pathway" where different causes of, and treatments for, the disorder appear to converge.

Success or Failure of Antidepressant Citalopram Predicted by Gene Variation
Press Release • August 01, 2007

A variation in a gene called GRIK4 appears to make people with depression more likely to respond to the medication citalopram (Celexa) than are people without the variation, a study by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, has found.

Faster-Acting Antidepressants Closer to Becoming a Reality
Press Release • July 24, 2007

A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of the weeks or months it takes for current antidepressants to work.

Improvement Following ADHD Treatment Sustained in Most Children
Press Release • July 20, 2007

Most children treated in a variety of ways for attention deficit hyperactivity disorder (ADHD) showed sustained improvement after three years in a major follow-up study funded by the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH).

In Second Try to Treat Depression, Cognitive Therapy Generally As Effective As Medication
Science Update • May 01, 2007

Switching to or adding cognitive therapy (CT) after a first unsuccessful attempt at treating depression with an antidepressant medication is generally as effective as switching to or adding another medication, but remission may take longer to achieve

Intensive Psychotherapy More Effective Than Brief Therapy for Treating Bipolar Depression
Press Release • April 02, 2007

Patients taking medications to treat bipolar disorder are more likely to get well faster and stay well if they receive intensive psychotherapy, according to results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), funded by the National Institutes of Health’s (NIH) National Institute of Mental Health (NIMH).

Study Sheds Light on Medication Treatment Options for Bipolar Disorder
Press Release • March 28, 2007

For depressed people with bipolar disorder who are taking a mood stabilizer, adding an antidepressant medication is no more effective than a placebo (sugar pill), according to results published online on March 28, 2007 in the New England Journal of Medicine.

Landmark Council Session Spotlights “Real World” Trials
Science Update • December 21, 2006

Principal investigators of NIMH's four large-scale clinical trials presented study results and their implications at the National Advisory Mental Health Council meeting on September 15, 2006.

Odds of Beating Depression Diminish as Additional Treatment Strategies are Needed
Science Update • November 01, 2006

An overall assessment of the nation's largest real-world study of treatment-resistant depression suggests that a patient with persistent depression can get well after trying several treatment strategies, but his or her odds of beating the depression diminish as additional treatment strategies are needed.

Subsequent Treatment Strategies for Persistent Depression Yield Modest Results
Science Update • September 01, 2006

Patients with treatment-resistant depression had a modest chance of becoming symptom-free when they tried different treatment strategies after two or three failed treatments, according to results from the nation's largest real-world study of depression.

College Women at Risk for Eating Disorder May Benefit From Online Intervention
Press Release • August 07, 2006

A long-term, large-scale study has found that an Internet-based intervention program may prevent some high risk, college-age women from developing an eating disorder.

Targeted Therapy Halves Suicide Attempts in Borderline Personality Disorder
Science Update • July 03, 2006

Dialectical Behavior Therapy (DBT) reduced suicide attempts by half compared with other types of psychotherapy available in the community in patients with borderline personality disorder, an NIMH-funded study has found.

Properly Timed Light, Melatonin Lift Winter Depression by Syncing Rhythms
Science Update • May 01, 2006

Most Seasonal Affective Disorder (SAD) symptoms stem from daily body rhythms that have gone out-of-sync with the sun, a NIMH-funded study has found.

Studies Offer New Information About Treatment Choices for Schizophrenia — Phase 2 Results
Science Update • April 01, 2006

A national clinical trial comparing clozapine with other new-generation antipsychotic medications for the treatment of chronic schizophrenia has shown that people who switched to clozapine from their first medication because it failed to manage symptoms adequately were twice as likely to continue treatment as patients who switched to other antipsychotic medications.

New Strategies Help Depressed Patients Become Symptom-Free
Press Release • March 23, 2006

Results of the nation’s largest depression study show that one in three depressed patients who previously did not achieve remission using an antidepressant became symptom-free with the help of an additional medication and one in four achieved remission after switching to a different antidepressant.

Maintenance Treatment Prevents Recurrence in Older Adults with Single-Episode Depression
Press Release • March 16, 2006

People age 70 and older who continued taking the antidepressant that helped them to initially recover from their first episode of depression were 60 percent less likely to experience a new episode of depression over a two-year study period than those who stopped taking the medication, according to a study funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health.

Early Findings from Largest NIMH-Funded Research Program on Bipolar Disorder Begin to Build Evidence-Base on Best Treatment Options
Science Update • February 01, 2006

Findings from an NIMH research program on bipolar disorder provide much needed long-term data on the chronic, recurrent course of the disorder, and begin the work of building an evidence-base on the best treatments for those with the disorder.

Initial Results Help Clinicians Identify Patients with Treatment-Resistant Depression
Press Release • January 06, 2006

Initial results of the nation’s largest clinical trial for depression have helped clinicians to track “real world” patients who became symptom-free and to identify those who were resistant to the initial treatment.

Cognitive Therapy Reduces Repeat Suicide Attempts by 50 Percent
Press Release • August 02, 2005

Recent suicide attempters treated with cognitive therapy were 50 percent less likely to try to kill themselves again within 18 months than those who did not receive the therapy, report researchers supported by the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH) and the Center for Disease Control and Prevention (CDC).

Psychotherapy, Medications Best for Youth With Obsessive Compulsive Disorder
Press Release • October 28, 2004

Children and adolescents with Obsessive Compulsive Disorder (OCD) respond best to a combination of both psychotherapy and an antidepressant, a major clinical trial has found.

Combination Treatment Most Effective in Adolescents with Depression
Press Release • August 17, 2004

A clinical trial of 439 adolescents with major depression has found a combination of medication and psychotherapy to be the most effective treatment.

Research to Test Treatment of Cognitive Dysfunction in Schizophrenia
Press Release • May 06, 2004

The National Institute of Mental Health (NIMH), of the National Institutes of Health (NIH), has awarded a four-year, $9 million contract to the University of California, Los Angeles (UCLA) and five other academic medical centers to create a network of Treatment Units for Research on Neurocognition and Schizophrenia (TURNS).

New Program Treats Rural Youth And Targets Barriers To Care
Press Release • July 29, 2003

Adolescents and teens with emotional and behavioral problems will receive treatment as part of a new study in eight of the poorest Appalachian counties in Eastern Tennessee.

Medication and Psychotherapy Treat Depression in Low-Income Minority Women
Press Release • July 01, 2003

Treatment with medication or psychotherapy reduced depressive symptoms in women from minority populations, according to research funded by the National Institute of Mental Health (NIMH).

Treatment for Minor Depression
Press Release • March 21, 2003

In a new approach to research on minor depression, the National Institutes of Health (NIH) has launched a four-year study to determine the safety and effectiveness of St. John's wort, a common herbal supplement, and citalopram, a standard antidepressant, compared to placebo.

Placebo, Antidepressant May Lift Depression Via Common Mechanism
Press Release • May 01, 2002

Whether it's a widely prescribed medication or a placebo, a successful treatment for depression must trigger a common pattern of brain activity changes, suggests a team of researchers funded by the National Institute of Mental Health.

Find Science News by Topic

Or Find Science News by Year

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002